Tradestie Institutional Equity Comparison Engine

RGNX vs ABSI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ABSI Overall Edge

ABSI Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Absci Corporation Common Stock (ABSI) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while RGNX counters with relative strength in Valuation. Fundamentally, RGNX trades at N/M Forward P/E with -120.4% operating margin (-69.2% YoY revenue) versus ABSI at N/M Forward P/E and -9108.3% operating margin (-19.6% YoY). In options structure, RGNX sits in BREAKDOWN (52nd %ile IV; Dealer Gamma Walls on Pro) against ABSI sits in BREAKDOWN (15th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RGNX
RGNX N/M vs ABSI N/M Fwd P/E
Growth & Margin Winner ABSI
Op Margin -120.4% vs -9108.3% ยท YoY -69.2% vs -19.6%
Momentum & Technical Winner ABSI
1Y -35.8% vs +192.6% ยท 52W Pos 19% vs 53%
Options & Structure Winner ABSI
BREAKDOWN (52nd %ile IV) vs BREAKDOWN (15th %ile IV)
RGNX NASDAQ
REGENXBIO Inc.
Biological Products, (No Disgnostic Substances)
$7.47
-2.23% 1D
Market Cap $500.9M
1M Return +7.87%
1Y Return -35.82%
Forward P/E N/M
Unified AI Score
45.3 / 100 HOLD
Tech 36.0 Fund 44.0 Flow 69.0 Mom 50.0
ABSI NASDAQ
Absci Corporation Common Stock
Services-Commercial Physical & Biological Research
$7.72
-8.58% 1D
Market Cap $1.6B
1M Return -6.36%
1Y Return +192.61%
Forward P/E N/M
Unified AI Score
41.2 / 100 SELL
Tech 30.0 Fund 51.0 Flow 71.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RGNX -35.82% ABSI +192.61% Spread: +228.43 pp (ABSI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period RGNX Revenue ABSI Revenue RGNX Op. Margin ABSI Op. Margin Margin Edge
FY2018 $220M N/A 40.3% N/A RGNX
FY2019 $40M N/A -422.9% N/A RGNX
FY2020 $150M $0M -77.1% -278.3% RGNX
FY2021 $470M $0M 34.0% -1573.4% RGNX
FY2022 $110M $10M -233.2% -1857.5% RGNX
FY2023 $90M $10M -297.1% -2020.2% RGNX
FY2024 $80M $0M -280.0% -2401.6% RGNX
FY2025 $170M $0M -94.6% -4297.0% RGNX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RGNX (3) vs ABSI (5)
Institutional Metric RGNX ABSI Criterion Row Winner
Market Capitalization Scale $500.9M $1.6B Larger Scale ABSI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -69.2% -19.6% Higher Growth ABSI
Operating Margin (TTM) Profitability -120.4% -9108.3% Higher Margin RGNX
Net Profit Margin Profitability -113.9% 0.0% Higher Margin ABSI
Return on Equity (ROE) Capital Efficiency -113.2% -58.6% Higher ROE ABSI
52-Week Range Position Momentum 19% ($5โ€“$16) 53% ($2โ€“$13) Stronger Trend ABSI
Beta / 30D Volatility Risk Regime 1.81ฮฒ ยท 76% Vol 3.31ฮฒ ยท 126% Vol Lower Realized Risk RGNX
Unified Institutional Score Composite Signal 45.3 / 100 (HOLD) 41.2 / 100 (SELL) Higher Composite RGNX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RGNX vs ABSI Buy Guide
RGNX BREAKDOWN
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 52nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live RGNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABSI BREAKDOWN
97d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 15th %ile
IV Regime Compressed (<25th %ile)
Live ABSI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RGNX nor ABSI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.